全文获取类型
收费全文 | 18487篇 |
免费 | 1397篇 |
国内免费 | 68篇 |
专业分类
耳鼻咽喉 | 149篇 |
儿科学 | 554篇 |
妇产科学 | 562篇 |
基础医学 | 2614篇 |
口腔科学 | 311篇 |
临床医学 | 2090篇 |
内科学 | 3492篇 |
皮肤病学 | 492篇 |
神经病学 | 1905篇 |
特种医学 | 521篇 |
外科学 | 1994篇 |
综合类 | 114篇 |
一般理论 | 7篇 |
预防医学 | 1985篇 |
眼科学 | 429篇 |
药学 | 1078篇 |
1篇 | |
中国医学 | 21篇 |
肿瘤学 | 1633篇 |
出版年
2024年 | 19篇 |
2023年 | 220篇 |
2022年 | 266篇 |
2021年 | 693篇 |
2020年 | 475篇 |
2019年 | 594篇 |
2018年 | 769篇 |
2017年 | 521篇 |
2016年 | 625篇 |
2015年 | 686篇 |
2014年 | 846篇 |
2013年 | 1144篇 |
2012年 | 1660篇 |
2011年 | 1638篇 |
2010年 | 834篇 |
2009年 | 792篇 |
2008年 | 1193篇 |
2007年 | 1237篇 |
2006年 | 1079篇 |
2005年 | 992篇 |
2004年 | 866篇 |
2003年 | 788篇 |
2002年 | 745篇 |
2001年 | 122篇 |
2000年 | 86篇 |
1999年 | 101篇 |
1998年 | 112篇 |
1997年 | 109篇 |
1996年 | 67篇 |
1995年 | 59篇 |
1994年 | 56篇 |
1993年 | 61篇 |
1992年 | 53篇 |
1991年 | 36篇 |
1990年 | 28篇 |
1989年 | 33篇 |
1988年 | 20篇 |
1987年 | 14篇 |
1986年 | 28篇 |
1985年 | 25篇 |
1984年 | 26篇 |
1983年 | 23篇 |
1982年 | 25篇 |
1981年 | 15篇 |
1979年 | 13篇 |
1978年 | 21篇 |
1977年 | 11篇 |
1972年 | 15篇 |
1969年 | 12篇 |
1967年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Martin R. Späth Malte P. Bartram Nicolàs Palacio-Escat K. Johanna R. Hoyer Cedric Debes Fatih Demir Christina B. Schroeter Amrei M. Mandel Franziska Grundmann Giuliano Ciarimboli Andreas Beyer Jayachandran N. Kizhakkedathu Susanne Brodesser Heike Göbel Jan U. Becker Thomas Benzing Bernhard Schermer Martin Höhne Markus M. Rinschen 《Kidney international》2019,95(2):333-349
2.
3.
Interprofessional collaboration and communication in nursing homes: a qualitative exploration of problems in medical care for nursing home residents – study protocol
下载免费PDF全文
![点击此处可从《Journal of advanced nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
4.
5.
6.
7.
8.
Marco Maruzzo Umberto Basso Eugenio Borsatti Laura Evangelista Filippo Alongi Orazio Caffo Francesca Maines Sara Galuppo Rocco De Vivo Fable Zustovich Dario Palleschi Andrea Zivi Teodoro Sava Mariella Sorarù Roberto Iacovelli Maurizio Nicodemo Susanne Baier Lucia Fratino Vittorina Zagonel 《Clinical genitourinary cancer》2019,17(1):e187-e194
Background
Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.Patients and Methods
We conducted a multicenter retrospective analysis in the Triveneto region of Italy.Results
One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.Conclusion
This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined. 相似文献9.
Martina A. Steurer Jean Costello Rebecca J. Baer Scott P. Oltman Sky K. Feuer Tania Pacheco-Werner Elizabeth Rogers Marta M. Jankowska Jessica Block Molly McCarthy Matthew S. Pantell Christina Chambers Kelli K. Ryckman Laura L. Jelliffe-Pawlowski 《Paediatric and perinatal epidemiology》2020,34(2):130-138
10.
Gabi Mueller Claudio Perret Christina M Spengler 《Journal of rehabilitation medicine》2006,38(6):381-386
OBJECTIVE: Respiratory muscle endurance of able-bodied persons, assessed by normocapnic hyperpnoea at 70% of their maximal voluntary ventilation, usually ranges from 10 to 20 minutes. The aim of this study was to determine the level of ventilation that patients with paraplegia and tetraplegia can sustain for 10-20 minutes to later be used as the guideline for respiratory muscle endurance training. DESIGN: Pilot study; cross-over setting. SUBJECTS: Two groups, 8 patients with paraplegia and 6 with tetraplegia. METHODS: Respiratory muscle endurance tests were performed at 3 different intensities of normocapnic hyperpnoea, i.e. 20%, 40% and 60% maximal voluntary ventilation. Subjects performed partial re-breathing from a bag to assure normocapnia. Respiratory endurance was separately analysed for patients with paraplegia and tetraplegia. RESULTS: Mean respiratory endurance times were 46.0, 18.9 and 4.2 minutes at 20%, 40% and 60% maximal voluntary ventilation in patients with tetraplegia and 51.8, 38.8 and 12.2 minutes in patients with paraplegia. The duration differed significantly at 60% maximal voluntary ventilation between the groups. CONCLUSION: Minute ventilation to perform respiratory muscle endurance training can be set at around 40% of maximal voluntary ventilation for patients with tetraplegia and around 60% of maximal voluntary ventilation for patients with paraplegia, as these levels can be sustained for 10-20 minutes. 相似文献